Subscription is free, you'll receive our managed funds & investment newsletter, it provides insight and discounts for the DIY investor...
Healthscope is the latest company to enter the retail bond market with a five and a half year bond (Healthscope Notes).
Healthscope, a private healthcare service provider and operator of private hospitals and pathology labs around Australia, Malaysia, Singapore and New Zealand, was privatised by the Carlyle Group and TPG in October of this year. They are looking to raise between $170m and $215m to refinance the bridging loan facility utilised during the acquisition.
Overall, Healthscope
ANZ has just announced the launch of its new hybrid security, CPS 2. The first round of funding is open through a broker firm allocation, prior to general offer and institutional offer before listing in December.
The securities will be rated A+ by agency Standard & Poor’s meaning they are an investment grade hybrid considered relatively low risk.
CPS 2 will pay a quarterly coupon of between 3.10% and 3.30% over the 90 day bank bill swap rate (BBSW), currently 3.90%, with exact
